Date Filed | Type | Description |
05/30/2023 |
4
| Socks David A (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns:
| Granted 9,000 shares
@ $0 Granted 15,000 options to buy
@ $11.72, valued at
$175.8k
|
|
05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/28/2022 |
3
| Socks David A (CFO & Chief Business Officer) has filed a Form 3 on HilleVax, Inc. |
10/08/2021 |
4
| Socks David A (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns:
| Sold 15,471 shares
@ $32.6639, valued at
$505.3k
Sold 2,529 shares
@ $32.049, valued at
$81.1k
|
|
09/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/18/2021 |
4
| Socks David A (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns:
| Sold 4,209 shares
@ $30.4704, valued at
$128.2k
Sold 13,791 shares
@ $31.4907, valued at
$434.3k
|
|
06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/12/2021 |
5
| Socks David A (Director) has filed a Form 5 on Phathom Pharmaceuticals, Inc. |
02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/18/2020 |
4
| Socks David A (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns:
| Sold 5,000 shares
@ $46.2205, valued at
$231.1k
Sold 13,292 shares
@ $47.3492, valued at
$629.4k
Sold 12,954 shares
@ $48.19, valued at
$624.3k
Sold 200 shares
@ $48.99, valued at
$9.8k
Sold 35,197 shares
@ $40.4894, valued at
$1.4M
Sold 12,915 shares
@ $41.4302, valued at
$535.1k
Sold 100 shares
@ $42, valued at
$4.2k
|
|
11/12/2020 |
4
| Socks David A (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns:
| Sold 5,207 shares
@ $41.9478, valued at
$218.4k
Sold 5,477 shares
@ $42.6663, valued at
$233.7k
Sold 100 shares
@ $44, valued at
$4.4k
Sold 7,880 shares
@ $41.2923, valued at
$325.4k
Sold 4,601 shares
@ $42.3114, valued at
$194.7k
Sold 200 shares
@ $43.07, valued at
$8.6k
Sold 2,620 shares
@ $38.1747, valued at
$100k
Sold 3,354 shares
@ $39.224, valued at
$131.6k
Sold 903 shares
@ $40.3605, valued at
$36.4k
|
|
02/10/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
10/24/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/15/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/11/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/20/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/13/2010 |
4
| Socks David A (SVP) has filed a Form 4 on CADENCE PHARMACEUTICALS INC
Txns:
| Sold 10,000 shares
@ $9.3076, valued at
$93.1k
|
|
03/29/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/09/2010 |
4
| Socks David A (SVP) has filed a Form 4 on CADENCE PHARMACEUTICALS INC
Txns:
| Sold 10,000 shares
@ $9.2973, valued at
$93k
|
|
02/09/2010 |
4
| Socks David A (SVP) has filed a Form 4 on CADENCE PHARMACEUTICALS INC
Txns:
| Sold 12,500 shares
@ $10.2552, valued at
$128.2k
|
|
01/12/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/04/2010 |
4
| Socks David A (SVP) has filed a Form 4 on CADENCE PHARMACEUTICALS INC
Txns:
| Exercised 25,000 options to buy
@ $0.4, valued at
$10k
|
|
12/18/2009 |
4
| Socks David A (SVP) has filed a Form 4 on CADENCE PHARMACEUTICALS INC
Txns:
| Sold 2,500 shares
@ $10, valued at
$25k
|
|
12/16/2009 |
4
| Socks David A (SVP) has filed a Form 4 on CADENCE PHARMACEUTICALS INC
Txns:
| Sold 10,000 shares
@ $9.3427, valued at
$93.4k
|
|
11/10/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/13/2009 |
4
| Socks David A (SVP) has filed a Form 4 on CADENCE PHARMACEUTICALS INC |
09/15/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/02/2009 |
4
| Socks David A (SVP) has filed a Form 4 on CADENCE PHARMACEUTICALS INC |
|